Yazar "Yalinkaya, A" seçeneğine göre listele
Listeleniyor 1 - 11 / 11
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe Accidental epidural injection of ephedrine(Churchill Livingstone, 2004) Olmez, G; Yalinkaya, A[Abstract Not Available]Öğe Aggressive angiomyxoma of the female pelvis and the labium(Wiley-Blackwell, 2003) Yalinkaya, A; Askar, I; Bayhan, G; Kilinc, N; Yayla, M[Abstract Not Available]Öğe The comparison of amino-terminal probrain natriuretic peptide levels in preeclampsia and normotensive pregnancy(Walter De Gruyter Gmbh, 2005) Kale, A; Kale, E; Yalinkaya, A; Akdeniz, N; Canoruç, NObjective: The purpose of this study was to evaluate the levels of amino-terminal probrain natriuretic peptide (Nt pro-BNP) in preeclampsia in comparison with normotensive pregnancy. Materials and methods: Women with preeclampsia (proteinuria >= 300 mg/24 In and at least two readings of systolic blood pressure >= 140 mm Hg and diastolic blood pressure >= 90 mm Hg) (n=32 mild preeclampsia and n=8 severe preeclampsia) were compared with normotensive women (n=40). Serum Nt pro-BNP was measured using an electrochemiluminescence immunoassay (ECLIA) method (Nt pro-BNP, Roche) with a Roche modular analytics E170 immunoassay analyzer. Statistical analysis was carried out by the Student t-test, and a P value of <0.05 was accepted as statistically significant. Results: The median serum Nt pro-BNP was 430 +/- 28.91 pg/mL in preeclampsia. The levels of serum Nt pro-BNP were 74 16.82 pg/mL in normotensive pregnant women (P < 0.001) and significantly higher in women with preeclampsia (P < 0.001). Conclusion: The higher levels of serum Nt pro-BNP in preeclamptic women may be an indicator of high left-ventricular filling pressure, and indicate left-ventricular diastolic dysfunction.Öğe Delivery of dead fetus from inside urinary bladder with uterine perforation: Case report and review of literature(Elsevier Science Inc, 2005) Atug, F; Akay, F; Aflay, U; Sahin, H; Yalinkaya, AThe incidence of cesarean sections has increased radically worldwide in the second half of the 20th century, especially in developing countries. Generally, a trial of labor after a cesarean section is safely accepted. However, a trial of labor may lead to serious complications, including unpredicted ones, such as rupture of the uterus during labor with concomitant injury to the bladder. We report the delivery of a dead fetus through the urinary bladder during labor. (c) 2005 Elsevier Inc.Öğe Laparoscopy-assisted transinguinal extracorporeal gonadectomy in six patients with androgen insensitivity syndrome(Elsevier Science Inc, 2003) Yalinkaya, A; Yayla, MObjective: To describe a new surgical technique to treat prophylactic gonadectomy in patients with androgen insensitivity syndrome. Design: Prospective study. Setting: University hospital. Patient(s): Six patients with androgen insensitivity syndrome. Intervention(s): Laparoscopy-assisted transinguinal or suprapubic extracorporeal gonadectomy. Main Outcome Measure(s): Accessibility, operation time, and cost-effectiveness. Result(s): Laparoscopy-assisted transinguinal extracorporeal gonadectomy under general anesthesia was performed successfully, with no complications, in all patients as a one-day procedure. The operation times were 12 to 22 minutes (average, 16 minutes). Histopathologic examination revealed testicles in all cases. The cost of each operation was approximately $500 to $1,000. Conclusion(s): Laparoscopy-assisted transinguinal or suprapubic and extracorporeal gonadectomy has several advantages over laparotomy and operative laparoscopy, including short operating time, safety, simplicity, and cost-effectiveness. (C) 2003 by American Society for Reproductive Medicine.Öğe Mucinous tumors of the ovary(I R O G Canada, Inc, 2001) Yaldiz, M; Uzunlar, AK; Kilinç, N; Yalinkaya, A; Akkus, M; Tunik, SOvarian mucinous tumors stem from ovarian surface epithelium and are divided into benign, borderline and malignant. If is difficult to differentiate borderline and malignant mucinous tumors. Thirty-eight cases of ovarian mucinous tumors which were diagnosed at the Pathology Department of Dicle University Medical Faculty were reviewed. Of these, 18 (47.3%), six (15.7%) and 14 (36.8%) were benign, borderline and malignant. respectively. The patients' ages ranged from 18 to 67 (average 44.5) years. Bilaterality was detected in 1/18 (5.5%). 0/6 and 4/14 (28.5%) of benign, borderline and malignant mucinous tumors, respectively. Mean tumor size was 26.4 cm. Microscopically, there was no stratification in the benign tumors. The borderline tumors had papillary infoldings and 2-3 layers of atypical epithelial cells but no invasion of the stroma. Malignant tumors had four or more layers of atypical epithelial cells and stromal invasion.Öğe Primary gastric choriocarcinoma(I R O G Canada, Inc, 2000) Bayhan, G; Yaldiz, M; Yalinkaya, A; Kilinç, N; Gül, T; Erden, AC[Abstract Not Available]Öğe The relationship between thrombophilic mutations and preeclampsia: a prospective case-control study(K Faisal Spec Hosp Res Centre, 2006) Yalinkaya, A; Erdemoglu, M; Akdeniz, N; Kale, A; Kale, EBACKGROUND: Preeclampsia and its association with thrombophilia remain controversial, dueto inconsistent results in different studies, which include different ethnic groups, selection criteria, and patient numbers. The aim of this study was to determine the relationship between thrombophilia and preeclamptic patients in our region. METHODS: In a prospective case-control study, we compared 100 consecutive women with preeclampsia and eclampsia (group 1) with 100 normal pregnant women (group 2). All women were tested two months after delivery for mutations of factor V Leiden, methylenetetrahydrofolate reductase (MTHFR), and prothrombin gene mutation as well as for deficiencies of protein C, protein S, and antithrombin III. RESULTS: A thrombophilic mutation was found in 42 (42%) and 28 (28%) women in group 1 and group 2, respectively (P=0.27, OR 1.5, 95% CI 1.0-2.2). The incidence of Factor V Leiden mutation (heterozygous), prothrombin mutation (heterozygous), prothrombin mutation (homozygous), MTHFR mutation (homozygous) was not statistically significant in group 1 compared with group 2 (P > 0.05). Also, deficiencies of protein S, protein C, and antithrombin III were not statistically significant in group 1 compared with group 2 (P > 0.05). CONCLUSION: There was no difference in thrombophilic mutations between preeclamptic patients and normal pregnant women in our region. Therefore, we suggest that preeclamptic patients should not be tested for thrombophilia.Öğe Spontaneous rupture of the ovarian artery following spontaneous vaginal birth(Saudi Med J, 2005) Kale, A; Akdeniz, N; Erdemoglu, M; Ozcan, Y; Yalinkaya, A[Abstract Not Available]Öğe Survival and reproductive function after treatment of immature ovarian teratoma(I R O G Canada, Inc, 2001) Uzunlar, AK; Yalinkaya, A; Yaldiz, M; Kilinç, N; Gül, TWe conducted a clinical and pathologic review of nine patients with immature ovarian teratoma. The histologic grade of the tumor seemed to be a reliable indicator of prognosis. Low stage and low grade immature ovarian teratomas have an excellent prognosis. Platinum-based chemotherapy has been confirmed to be effective in the management of patients with ovarian germ cell tumors. Low grade pure ovarian immature teratoma is a potentially curable disease and a fertility-sparing surgical approach is possible,Öğe The use of recombinant factor VIIa in a primigravida with Glanzmann's thrombasthenia during delivery(Walter De Gruyter Gmbh, 2004) Kale, A; Bayhan, G; Yalinkaya, A; Yayla, MGlanzmanns thrombasthenia is an inherited hemorrhagic disorder characterized by a severe reduction in, or absence of, platelet aggregation in response to multiple physiologic agonists due to qualitative or quantitative abnormalities of platelet glycoprotein IIbIIIa. Glanzmanns thrombasthenia is characterized by potentially major mucocutaneous bleeding and prolonged bleeding time. Platelet counts, platelet morphology, prothrombin, and activated thromboplastin times are all within normal ranges in patients with Glanzmanns thrombasthenia. Pregnancy and delivery are rare in Glanzmann thrombasthenia patients and have been associated with immediate postpartum hemorrhage. We describe the peripartum management of a 31-yearold primipara with Glanzmanns thrombasthenia who underwent spontaneous vaginal delivery. Four units of singledonor platelets, two units of packed red blood cells, 36 g/kg recombinant human coagulation Factor VIIa (rFVIIa) were given during peripartum management.
